Which Is the Most Appropriate PI3K Inhibitor for Breast Cancer Patients with or without PIK3CA Status Mutant? A Systematic Review and Network Meta-Analysis
哪种PI3K抑制剂最适合PIK3CA状态突变或非突变的乳腺癌患者?一项系统评价和网络荟萃分析
期刊:Biomed Research International
影响因子:2.3
doi:10.1155/2020/7451576
Wang, Shu; Liu, Mingyue; Lian, Siheng; Liu, Naiming; Zhang, Guibin; Zhao, Qingchun; Zhang, Yingshi; Jian, Lingyan